FDA Approved Biogen Alzheimer’s Drug Despite Some Staff Concerns – The Wall Street Journal

The U.S. Food and Drug Administration approved the first new Alzheimers drug in decades over the objection of agency statisticians who said there was insufficient evidence to support approval, accord… [+1102 chars]